Search results for:
haemophilus b conjugate vaccine
haemophilus b conjugate vaccine
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
PedvaxHIB (PRP-OMP) |
INJECTION, INJECTABLE |
|
|
|
|
|
ActHIB (PRP-T) |
POWDER FOR INJECTION, INTRAMUSCULAR |
- |
|
|
|
|
Hiberix (PRP-T) |
POWDER FOR INJECTION, INTRAMUSCULAR |
- |
|
|
|
|
Last updated: Jul. 24, 2019
HIBERIX is the inpatient formulary product and can be used for both the primary vaccination dose series and the booster dose.
ActHIB is classified as NON-FORMULARY.
HIBERIX (GSK) or PEDVAXHIB (Merck) may be ordered for outpatient clinic stock.
HIBERIX Reviewed: November 17, 2009
Updated: June 22, 2018 (GSK Contract)